These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8255474)

  • 1. Nerve growth factor reverses neuronal atrophy in a Down syndrome model of age-related neurodegeneration.
    Holtzman DM; Li Y; Chen K; Gage FH; Epstein CJ; Mobley WC
    Neurology; 1993 Dec; 43(12):2668-73. PubMed ID: 8255474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse model of neurodegeneration: atrophy of basal forebrain cholinergic neurons in trisomy 16 transplants.
    Holtzman DM; Li YW; DeArmond SJ; McKinley MP; Gage FH; Epstein CJ; Mobley WC
    Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1383-7. PubMed ID: 1741393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
    García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
    Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal choline supplementation protects against age-associated cholinergic and GABAergic basal forebrain neuron degeneration in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.
    Gautier MK; Kelley CM; Lee SH; Alldred MJ; McDaid J; Mufson EJ; Stutzmann GE; Ginsberg SD
    Neurobiol Dis; 2023 Nov; 188():106332. PubMed ID: 37890559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion.
    Cooper JD; Salehi A; Delcroix JD; Howe CL; Belichenko PV; Chua-Couzens J; Kilbridge JF; Carlson EJ; Epstein CJ; Mobley WC
    Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10439-44. PubMed ID: 11504920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates.
    Koliatsos VE; Clatterbuck RE; Nauta HJ; Knüsel B; Burton LE; Hefti FF; Mobley WC; Price DL
    Ann Neurol; 1991 Dec; 30(6):831-40. PubMed ID: 1789695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration.
    Salehi A; Delcroix JD; Belichenko PV; Zhan K; Wu C; Valletta JS; Takimoto-Kimura R; Kleschevnikov AM; Sambamurti K; Chung PP; Xia W; Villar A; Campbell WA; Kulnane LS; Nixon RA; Lamb BT; Epstein CJ; Stokin GB; Goldstein LS; Mobley WC
    Neuron; 2006 Jul; 51(1):29-42. PubMed ID: 16815330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cultured basal forebrain cholinergic neurons in contact with cortical cells display synapses, enhanced morphological features, and decreased dependence on nerve growth factor.
    Ha DH; Robertson RT; Ribak CE; Weiss JH
    J Comp Neurol; 1996 Sep; 373(3):451-65. PubMed ID: 8889938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Nerve Growth Factor Metabolic Pathway Dysregulation as Cause of Alzheimer's Cholinergic Atrophy.
    Do Carmo S; Kannel B; Cuello AC
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental deficits and staging of dynamics of age associated Alzheimer's disease neurodegeneration and neuronal loss in subjects with Down syndrome.
    Wegiel J; Flory M; Kuchna I; Nowicki K; Wegiel J; Ma SY; Zhong N; Bobrowicz TW; de Leon M; Lai F; Silverman WP; Wisniewski T
    Acta Neuropathol Commun; 2022 Jan; 10(1):2. PubMed ID: 34983655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term basal forebrain cholinergic-rich grafts derived from trisomy 16 mice do not develop beta-amyloid pathology and neurodegeneration but demonstrate neuroinflammatory responses.
    Stahl T; Goldammer A; Luschekina E; Beck M; Schliebs R; Bigl V
    Int J Dev Neurosci; 1998; 16(7-8):763-75. PubMed ID: 10198823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal Choline Supplementation Alters Basal Forebrain Cholinergic Neuron Gene Expression in the Ts65Dn Mouse Model of Down Syndrome.
    Kelley CM; Ginsberg SD; Alldred MJ; Strupp BJ; Mufson EJ
    Dev Neurobiol; 2019 Jul; 79(7):664-683. PubMed ID: 31120189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cholinergic system in aging and neuronal degeneration.
    Schliebs R; Arendt T
    Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal Forebrain Cholinergic Neurons: Linking Down Syndrome and Alzheimer's Disease.
    Martinez JL; Zammit MD; West NR; Christian BT; Bhattacharyya A
    Front Aging Neurosci; 2021; 13():703876. PubMed ID: 34322015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nerve Growth Factor Compromise in Down Syndrome.
    Do Carmo S; Kannel B; Cuello AC
    Front Aging Neurosci; 2021; 13():719507. PubMed ID: 34434101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease and NGF signaling.
    Salehi A; Delcroix JD; Swaab DF
    J Neural Transm (Vienna); 2004 Mar; 111(3):323-45. PubMed ID: 14991458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced survival and morphological features of basal forebrain cholinergic neurons in vitro: role of neurotrophins and other potential cortically derived cholinergic trophic factors.
    Ha DH; Robertson RT; Roshanaei M; Weiss JH
    J Comp Neurol; 1999 Apr; 406(2):156-70. PubMed ID: 10096603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attentional function and basal forebrain cholinergic neuron morphology during aging in the Ts65Dn mouse model of Down syndrome.
    Powers BE; Velazquez R; Kelley CM; Ash JA; Strawderman MS; Alldred MJ; Ginsberg SD; Mufson EJ; Strupp BJ
    Brain Struct Funct; 2016 Dec; 221(9):4337-4352. PubMed ID: 26719290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term transplants of mouse trisomy 16 hippocampal neurons, a model for Down's syndrome, do not develop Alzheimer's disease neuropathology.
    Stoll J; Balbo A; Ault B; Rapoport SI; Fine A
    Brain Res; 1993 May; 610(2):295-304. PubMed ID: 8319091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A noradrenergic lesion exacerbates neurodegeneration in a Down syndrome mouse model.
    Lockrow J; Boger H; Gerhardt G; Aston-Jones G; Bachman D; Granholm AC
    J Alzheimers Dis; 2011; 23(3):471-89. PubMed ID: 21098982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.